This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The intensive investigation of Field and coworkers¹ provides important information for those who care for nursing home (NH) residents. The findings are disturbing and might underestimate the true frequency of NH adverse drug events (ADEs) in the United States.

In earlier research, authors of this same group² suggested that the NHs they observed were likely to provide above-average care and to experience below-average ADEs—particularly since the NHs participated voluntarily and the proportion of proprietary NHs was below the national average. The latter point requires emphasis, particularly because the proportion of voluntary, nonprofit NHs across the United States is much lower than in the present study¹ (27% vs 39%), and residents of nonprofit NHs receive better quality services and experience better outcomes.³ It would be interesting to compare the frequency of ADEs in the voluntary, nonprofit NHs with that in the proprietary NHs observed by Field et al.¹

In addition, there . . . [Full Text of this Article]